Determination of endogenous zeatin/IAA levels in selected fortune mandarin mutants against Alternaria alternata pv. citri
Mediterranean Agricultural Sciences · 2022
DOI: 10.29136/mediterranean.1088870 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediterranean Agricultural Sciences, 2022. Verfasst von Ertuğrul TURGUTOĞLU und 1 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Akdeniz University, Scientific Research Projects Coordination Unit.
Abstract (Originalsprache)
Alternaria brown spot is a serious disease in mandarins and mandarin hybrids. In this particular research, 9 Alterneria tolerant and 2 susceptible mutant individuals obtained from a series of in vitro and in vivo studies were used. Endogenous indole acetic acid (IAA) and zeatin hormone levels of the individuals were noted before and after the Alternaria disease inoculations in order to determine the hormonal variations during the research. It was determined that endogenous zeatin levels decreased after the inoculation compared to its initial levels. The indole acetic acid levels of the individuals increased after inoculation except for some individuals.
Förderung
- Akdeniz University, Scientific Research Projects Coordination Unit
Zitieren
APA
TURGUTOĞLU, E., & BAKTIR, İ. (2022). Determination of endogenous zeatin/IAA levels in selected fortune mandarin mutants against Alternaria alternata pv. citri. Mediterranean Agricultural Sciences. https://doi.org/10.29136/mediterranean.1088870
Vancouver
TURGUTOĞLU E, BAKTIR İ. Determination of endogenous zeatin/IAA levels in selected fortune mandarin mutants against Alternaria alternata pv. citri. Mediterranean Agricultural Sciences. 2022. doi:10.29136/mediterranean.1088870
BibTeX
@article{TURGUTOLU2022,
author = {TURGUTOĞLU, Ertuğrul and BAKTIR, İbrahim},
title = {Determination of endogenous zeatin/IAA levels in selected fortune mandarin mutants against Alternaria alternata pv. citri},
journal = {Mediterranean Agricultural Sciences},
year = {2022},
doi = {10.29136/mediterranean.1088870}
}
EUVIMED